MedMesh.i
Checkpoint
PubMed
Racine
Checkpoint
PubMed
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Vasculitis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Vascular Stiffness < Vasculitis < Vasculitis, Central Nervous System  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000002 (2020) Charlotte Girard-Guyonvarc'H ; Michele Iudici[Targeted therapies for connective tissue diseases and vasculitis].
000428 (2019) Cynthia M. Magro [États-Unis] ; Pierre Halteh [États-Unis] ; Luke C. Olson [États-Unis] ; Ilya Kister [États-Unis] ; Lee Shapiro [États-Unis]Linear scleroderma "en coup de sabre" with extensive brain involvement-Clinicopathologic correlations and response to anti-Interleukin-6 therapy.
000431 (2019) Keiichiro Kadoba [Japon] ; Kaoru Mizukawa [Japon] ; Keisuke Nishimura [Japon] ; Hiroyuki Murabe [Japon]Large vessel giant cell arteritis suggested by magnetic resonance imaging of the thigh: a potential mimicker of myositis, fasciitis and skeletal muscle vasculitis.
000615 (2018) Francesco Muratore [Italie] ; Giulia Pazzola [Italie] ; Alessandra Soriano [Italie] ; Nicol Pipitone [Italie] ; Stefania Croci [Italie] ; Martina Bonacini [Italie] ; Luigi Boiardi [Italie] ; Carlo Salvarani [Italie]Unmet Needs in the Pathogenesis and Treatment of Vasculitides.
000951 (2017) François Spertini [Suisse][Hope for chronic inflammatory diseases : the anti-IL-6 receptor monoclonal antibody tocilizumab].
000A16 (2017) Martin Sheppard [Royaume-Uni] ; Faidra Laskou [Royaume-Uni] ; Philip P. Stapleton [Royaume-Uni] ; Shahryar Hadavi [Royaume-Uni] ; Bhaskar Dasgupta [Royaume-Uni]Tocilizumab (Actemra).
000B87 (2017) Ryota Sakai [Japon] ; Tsuneo Kondo [Japon] ; Takahiko Kurasawa [Japon] ; Eiko Nishi [Japon] ; Ayumi Okuyama [Japon] ; Kentaro Chino [Japon] ; Akiko Shibata [Japon] ; Yusuke Okada [Japon] ; Hirofumi Takei [Japon] ; Hayato Nagasawa [Japon] ; Koichi Amano [Japon]Current clinical evidence of tocilizumab for the treatment of ANCA-associated vasculitis: a prospective case series for microscopic polyangiitis in a combination with corticosteroids and literature review.
000E01 (2016) David Saadoun [France] ; Patrice Cacoub [France]Moving towards new treatments for vasculitis.
000F47 (2016) Özgül Mu Tu Koryürek ; Göknur Kalkan [Turquie]A new alternative therapy in dermatology: tocilizumab.
000F63 (2015) Michael Scharl ; Dominik Schaer ; Florence Vallelian[CME. Biologics in vasculitis].
000F77 (2015) Cheng-Pin Wu [République populaire de Chine] ; Chia-Wei Hsieh [République populaire de Chine] ; Der-Yuan Chen [République populaire de Chine] ; Bor-Jen Lee [République populaire de Chine] ; Chii-Shuenn Yang [République populaire de Chine]Tocilizumab-associated cutaneous reactive endotheliomatosis in a patient with rheumatoid arthritis.
001211 (2014) M. Fleck ; P M Aries [Allemagne] ; C. Iking-Konert[Vasculitis: update 2014].
001231 (2014) K. Takase [Royaume-Uni] ; S C Horton [Royaume-Uni] ; A. Ganesha [Royaume-Uni] ; S. Das [Royaume-Uni] ; A. Mchugh [Royaume-Uni] ; P. Emery [Royaume-Uni] ; S. Savic [Royaume-Uni] ; M H Buch [Royaume-Uni]What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort.
001365 (2014) Sarah M. Keidel [Royaume-Uni] ; Rachel K. Hoyles ; Nick M R. WilkinsonEfficacy of tocilizumab for interstitial lung disease in an undifferentiated autoinflammatory disorder partially responsive to anakinra.
001438 (2013) M. Fleck ; B. Hellmich[Vasculitis].
001528 (2013) Ratnesh Chopra [États-Unis] ; Nida Chaudhary ; Jonathan KayRelapsing polychondritis.
001648 (2012) P. Szturz [République tchèque] ; Z. Adam ; M. Moulis ; L. Smardová ; M. Klincová ; R. Slaisová ; R. Koukalová ; Z. Rehák ; P. Volfová ; J. Chovancová ; O. Stehlíková ; J. Mayer[Our experience in treatment of multicentric plasma-cell Castleman disease associated with vasculitis manifestations - case report and literature review].
001700 (2012) Ashima Makol [États-Unis] ; Lawrence E. Gibson ; Clement J. MichetSuccessful use of interleukin 6 antagonist tocilizumab in a patient with refractory cutaneous lupus and urticarial vasculitis.
001773 (2012) Camille Cohen ; Arsene Mekinian ; Nathalie Saidenberg-Kermanac'H ; Jerôme Stirnemann ; Pierre Fenaux ; Romain Gherardi ; Olivier FainEfficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis.
001878 (2011) Mariagrazia Catanoso [Italie] ; Nicol Pipitone ; Luca Magnani ; Luigi Boiardi ; Carlo SalvaraniNew indications for biological therapies.
001A48 (2010) Zoltán Szekanecz [Hongrie] ; Sándor Szánt ; Zoltán Szab ; Andrea Váncsa ; Szilvia Szamosi ; N Ra Bodnár ; Gabriella SzücsBiologics - beyond the joints.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Vasculitis" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Vasculitis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Vasculitis
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021